• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死患者血清骨保护素水平与冠状动脉疾病严重程度的关联

Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction.

作者信息

Cottin Yves, Issa Rany, Benalia Mourad, Mouhat Basile, Meloux Alexandre, Tribouillard Laura, Bichat Florence, Rochette Luc, Vergely Catherine, Zeller Marianne

机构信息

Cardiology Department, CHU Dijon Bourgogne, 21000 Dijon, France.

Equipe d'Accueil (EA 7460), Physiopathologie et Epidémiologie Cérébro-Cardiovasculaires (PEC2), Faculté des Sciences de Santé Université de Bourgogne-Franche Comté, 7 Bd Jeanne d'Arc, 21000 Dijon, France.

出版信息

J Clin Med. 2021 Sep 23;10(19):4326. doi: 10.3390/jcm10194326.

DOI:10.3390/jcm10194326
PMID:34640343
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8509596/
Abstract

BACKGROUND

Osteoprotegerin (OPG), a glycoprotein of the tumour necrosis factor (TNF) superfamily, is one of the main biomarkers for vascular calcification.

AIM

We aimed to evaluate the association between serum OPG levels and extent of coronary lesions in patients with acute myocardial infarction (MI).

METHODS

Consecutive patients hospitalized for an acute MI who underwent coronary angiography were included. SYNTAX score was calculated to assess the severity of coronary artery disease. The population was analysed in low (5 (3-6)), medium (11 (9-13)) and high (20 (18-23)) tertiles of SYNTAX score.

RESULTS

Among the 378 patients included, there was a gradual increase in age, rate of diabetes, anterior wall location, and a reduction in left ventricular ejection fraction across the SYNTAX tertiles. OPG levels significantly increased across the tertiles (962 (782-1497), 1240 (870-1707), and 1464 (1011-2129) pg/mL, respectively ( < 0.001)). In multivariate analysis, OPG [OR(CI95%): 2.10 (1.29-3.49) 0.003], were associated with the high SYNTAX group, beyond hypercholesterolemia, CV history and reduced glomerular filtration rate.

CONCLUSION

We found an association between OPG levels and coronary lesions complexity patients with acute MI.

摘要

背景

骨保护素(OPG)是肿瘤坏死因子(TNF)超家族的一种糖蛋白,是血管钙化的主要生物标志物之一。

目的

我们旨在评估急性心肌梗死(MI)患者血清OPG水平与冠状动脉病变程度之间的关联。

方法

纳入因急性MI住院并接受冠状动脉造影的连续患者。计算SYNTAX评分以评估冠状动脉疾病的严重程度。将研究人群按SYNTAX评分的低(5(3 - 6))、中(11(9 - 13))和高(20(18 - 23))三分位数进行分析。

结果

在纳入的378例患者中,随着SYNTAX三分位数的升高,年龄、糖尿病发生率、前壁位置逐渐增加,左心室射血分数降低。OPG水平在三分位数间显著升高(分别为962(782 - 1497)、1240(870 - 1707)和1464(1011 - 2129)pg/mL,<0.001)。在多变量分析中,除高胆固醇血症、心血管病史和肾小球滤过率降低外,OPG[比值比(95%置信区间):2.10(1.29 - 3.49),P = 0.003]与高SYNTAX组相关。

结论

我们发现急性MI患者的OPG水平与冠状动脉病变复杂性之间存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9947/8509596/89244ca6877f/jcm-10-04326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9947/8509596/96bf46d953af/jcm-10-04326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9947/8509596/89244ca6877f/jcm-10-04326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9947/8509596/96bf46d953af/jcm-10-04326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9947/8509596/89244ca6877f/jcm-10-04326-g002.jpg

相似文献

1
Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction.急性心肌梗死患者血清骨保护素水平与冠状动脉疾病严重程度的关联
J Clin Med. 2021 Sep 23;10(19):4326. doi: 10.3390/jcm10194326.
2
Role of plaque calcification regulators osteoprotegerin and matrix Gla-proteins in stable angina and acute myocardial infarction.斑块钙化调节因子骨保护素和基质Gla蛋白在稳定型心绞痛和急性心肌梗死中的作用
J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):156-62. doi: 10.2459/JCM.0b013e328365b57d.
3
The role of the osteoprotegerin/RANKL/RANK axis and osteopontin in acute coronary syndrome.骨保护素/核因子κB受体活化因子配体/核因子κB受体活化因子轴及骨桥蛋白在急性冠状动脉综合征中的作用
Arch Cardiol Mex. 2024 May 29;95(1):1-8. doi: 10.24875/ACM.24000037.
4
Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?骨保护素能否用于在不同临床环境中识别冠心病的存在和严重程度?
Atherosclerosis. 2014 Oct;236(2):230-6. doi: 10.1016/j.atherosclerosis.2014.07.013. Epub 2014 Jul 21.
5
Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease.血清 FGF-23、klotho、胎球蛋白-A、骨桥蛋白、骨保护素和高敏 C 反应蛋白水平与冠状动脉疾病的关系。
Scand J Clin Lab Invest. 2020 Jul;80(4):277-281. doi: 10.1080/00365513.2020.1728786. Epub 2020 Feb 20.
6
The relationship between serum NT-proBNP levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute myocardial infarction.急性心肌梗死后患者血清 NT-proBNP 水平与 SYNTAX 评分评估的冠状动脉疾病严重程度的关系。
Turk J Med Sci. 2019 Oct 24;49(5):1366-1373. doi: 10.3906/sag-1902-26.
7
Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.ST 段抬高型心肌梗死中的骨保护素:预后影响及与磁共振成像心肌损伤标志物的相关性。
Int J Cardiol. 2013 Sep 1;167(5):2134-9. doi: 10.1016/j.ijcard.2012.05.101. Epub 2012 Jun 15.
8
Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.骨保护素对2型糖尿病患者冠状动脉钙化的预测价值及其与多排螺旋计算机断层扫描检测到的钙化程度的相关性
Endocr Metab Immune Disord Drug Targets. 2019;19(6):845-851. doi: 10.2174/1871530319666190211122858.
9
D-dimers are associated with coronary artery disease severity assessed using Syntax and Syntax II scores in patients with ST elevation myocardial infarction.D-二聚体与 ST 段抬高型心肌梗死患者应用 Syntax 和 Syntax II 评分评估的冠状动脉疾病严重程度相关。
Rev Port Cardiol (Engl Ed). 2020 Dec;39(12):687-693. doi: 10.1016/j.repc.2020.08.006. Epub 2020 Nov 13.
10
The value of serum osteoprotegerin levels in patients with angina like chest pain undergoing diagnostic coronary angiography.心绞痛样胸痛患者行诊断性冠状动脉造影术时血清护骨素水平的价值。
Cardiol J. 2013;20(3):261-7. doi: 10.5603/CJ.2013.0071.

引用本文的文献

1
Potential Biological and Genetic Links Between Dementia and Osteoporosis: A Scoping Review.痴呆症与骨质疏松症之间潜在的生物学和遗传联系:一项范围综述
Geriatrics (Basel). 2025 Jul 20;10(4):96. doi: 10.3390/geriatrics10040096.
2
Relationships between Osteopontin, Osteoprotegerin, and Other Extracellular Matrix Proteins in Calcifying Arteries.钙化动脉中骨桥蛋白、骨保护素及其他细胞外基质蛋白之间的关系
Biomedicines. 2024 Apr 11;12(4):847. doi: 10.3390/biomedicines12040847.
3
Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction.

本文引用的文献

1
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Rev Esp Cardiol (Engl Ed). 2021 Jun;74(6):544. doi: 10.1016/j.rec.2021.05.002.
2
Post-Infectious Myocardial Infarction: New Insights for Improved Screening.感染后心肌梗死:改进筛查的新见解
J Clin Med. 2019 Jun 11;8(6):827. doi: 10.3390/jcm8060827.
3
The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics.
ST 段抬高型心肌梗死与非 ST 段抬高型心肌梗死的差异基因表达模式。
Sci Rep. 2024 Feb 10;14(1):3424. doi: 10.1038/s41598-024-54086-w.
4
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods.PCSK9 抑制剂对动脉粥样硬化斑块稳定性的影响:生化和诊断影像学方法的评估。
Molecules. 2023 Aug 7;28(15):5928. doi: 10.3390/molecules28155928.
5
Causal effects for genetic variants of osteoprotegerin on the risk of acute myocardial infarction and coronary heart disease: A two-sample Mendelian randomization study.骨保护素基因变异对急性心肌梗死和冠心病风险的因果效应:一项两样本孟德尔随机化研究。
Front Cardiovasc Med. 2023 Mar 7;10:1041231. doi: 10.3389/fcvm.2023.1041231. eCollection 2023.
6
Osteoprotegerin Gene Polymorphisms Are Associated with Subclinical Atherosclerosis in the Mexican Mestizo Population.骨保护素基因多态性与墨西哥梅斯蒂索人群的亚临床动脉粥样硬化相关。
Diagnostics (Basel). 2022 Jun 10;12(6):1433. doi: 10.3390/diagnostics12061433.
骨保护素在血管钙化和骨代谢中的作用:开发新疗法的基础。
Calcif Tissue Int. 2019 Sep;105(3):239-251. doi: 10.1007/s00223-019-00573-6. Epub 2019 Jun 13.
4
Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015.根据再灌注治疗的使用情况,ST 段抬高型心肌梗死患者的特征、治疗和结局二十年变化趋势:来自 FAST-MI 项目 1995-2015 年的数据。
Am Heart J. 2019 Aug;214:97-106. doi: 10.1016/j.ahj.2019.05.007. Epub 2019 May 16.
5
Renal Failure Impact on the Outcomes of ST-Segment Elevation Myocardial Infarction Patients Due to a Left Main Coronary Culprit Lesion Treated Using a Primary Percutaneous Coronary Intervention.肾功能衰竭对因左主干罪犯病变接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者预后的影响。
J Clin Med. 2019 Apr 25;8(4):565. doi: 10.3390/jcm8040565.
6
TLR2 Promotes Vascular Smooth Muscle Cell Chondrogenic Differentiation and Consequent Calcification via the Concerted Actions of Osteoprotegerin Suppression and IL-6-Mediated RANKL Induction.TLR2 通过协同抑制骨保护素和 IL-6 介导的 RANKL 诱导促进血管平滑肌细胞软骨分化和随后的钙化。
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):432-445. doi: 10.1161/ATVBAHA.118.311874.
7
Effect of prior stroke on long-term outcomes of percutaneous coronary interventions in Chinese patients: A large single-center study.既往卒中对中国患者经皮冠状动脉介入治疗长期结局的影响:一项大型单中心研究。
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):E75-E80. doi: 10.1002/ccd.27705. Epub 2018 Nov 13.
8
Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease.稳定型冠状动脉疾病患者血清低密度脂蛋白胆固醇和载脂蛋白B与SYNTAX评分之间的关联
Angiology. 2018 Sep;69(8):724-729. doi: 10.1177/0003319717748771. Epub 2018 Jan 8.
9
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理指南:欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
10
The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases.骨保护素在血管和骨骼之间相互作用中的作用:作为代谢性心血管疾病标志物的潜在用途。
Pharmacol Ther. 2018 Feb;182:115-132. doi: 10.1016/j.pharmthera.2017.08.015. Epub 2017 Sep 1.